VENETIS, KONSTANTINOS
VENETIS, KONSTANTINOS
Dipartimento di Oncologia ed Emato-Oncologia
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies
2023 G. Grizzi, K. Venetis, N. Denaro, M. Bonomi, A. Celotti, A. Pagkali, J. Claus Hahne, G. Tomasello, F. Petrelli, N. Fusco, M. Ghidini
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study
2023 E.M.C. Rossi, A. Invento, F. Pesapane, E. Pagan, V. Bagnardi, N. Fusco, K. Venetis, V. Dominelli, C. Trentin, E. Cassano, L. Gilardi, M. Mazza, M. Lazzeroni, F. De Lorenzi, P. Caldarella, A. De Scalzi, A. Girardi, C. Sangalli, L. Alberti, V. Sacchini, V. Galimberti, P. Veronesi
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
BREAST CANCER DURING PREGNANCY AS A SPECIAL TYPE OF EARLY-ONSET BREAST CANCER: INSIGHTS INTO THE TUMOR MICROENVIRONMENT AND IMMUNE TRANSCRIPTOME
2023 K. Venetis
Trop-2 as an Actionable Biomarker in Breast Cancer
2023 G. Cursano, E. Frigo, E. Sajjadi, M. Ivanova, K. Venetis, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
In-house homologous recombination deficiency testing in ovarian cancer: A multi-institutional Italian pilot study
2023 F. Pepe, E. Guerini-Rocco, M. Fassan, N. Fusco, D. Vacirca, A. Ranghiero, K. Venetis, A. Rappa, S.V. Taormina, G. Russo, E. Rebellato, G. Munari, A. Moreno-Manuel, C. De Angelis, C. Zamagni, G. Valabrega, U. Malapelle, G. Troncone, M. Barberis, A. Iaccarino
Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”
2023 E. Sajjadi, K. Venetis, N. Fusco
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs)
2023 I. Piga, V. L'Imperio, L. Principi, C. Bellevicine, N. Fusco, F. Maffini, K. Venetis, M. Ivanova, D. Seminati, G. Casati, L. Pagani, S. Galimberti, G. Capitoli, M. Garancini, A.-. Gatti, F. Magni, F. Pagni
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
2022 E. Sajjadi, G. Gaudioso, A. Terrasi, F. Boggio, K. Venetis, M. Ivanova, L. Bertolasi, G. Lopez, L. Runza, A. Premoli, D. Lorenzini, E. Guerini-Rocco, S. Ferrero, V. Vaira, N. Fusco
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022 G. Corso, O. D'Ecclesiis, F. Magnoni, E. Mazzotta, F. Conforti, P. Veronesi, E. Sajjadi, K. Venetis, N. Fusco, S. Gandini
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
2022 E. Sajjadi, K. Venetis, M. Noale, H.A. Azim, C. Blundo, G. Bonizzi, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, M. Barberis, P. Veronesi, V.E. Galimberti, G. Viale, N. Fusco, F.A. Peccatori, E. Guerini-Rocco
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
2022 M. Ivanova, K. Venetis, E. GUERINI ROCCO, L. Bottiglieri, M. Giuseppe Mastropasqua, O. Garrone, N. Fusco, M. Ghidini
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
2022 A. de Sire, L. Lippi, K. Venetis, S. Morganti, E. Sajjadi, C. Curci, A. Ammendolia, C. Criscitiello, N. Fusco, M. Invernizzi
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
2022 K. Venetis, E. Crimini, E. Sajjadi, C. Corti, E. Guerini-Rocco, G. Viale, G. Curigliano, C. Criscitiello, N. Fusco
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer
2022 S. Morganti, A. Marra, K. Venetis, E. Sajjadi, L. Ascione, C. Corti, P. Zagami, M. Ivanova, L. Zattoni, G. Curigliano, N. Fusco, C. Criscitiello
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
2022 C. Corti, K. Venetis, E. Sajjadi, L. Zattoni, G. Curigliano, N. Fusco
Quality of Life Interventions in Breast Cancer Survivors: State of the Art in Targeted Rehabilitation Strategies
2022 M. Invernizzi, A. de Sire, K. Venetis, E. Cigna, S. Carda, M. Borg, C. Cisari, N. Fusco
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
2022 N. Fusco, E. Sajjadi, K. Venetis, M. Ivanova, S. Andaloro, E. Guerini-Rocco, E. Montagna, P. Caldarella, P. Veronesi, M. Colleoni, G. Viale
Mismatch Repair Status Characterization in Oncologic Pathology : Taking Stock of the Real-World Possibilities
2021 R. Piciotti, K. Venetis, E. Sajjadi, N. Fusco